Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308405425> ?p ?o ?g. }
- W4308405425 endingPage "689" @default.
- W4308405425 startingPage "676" @default.
- W4308405425 abstract "Quick thoracic ultrasonography (qTUS) is increasingly used as an on-farm method to diagnose clinical and subclinical pneumonia in dairy calves. The primary objective of this prospective cohort study was to describe dynamics of lung consolidation in a purchase-dependent production system for male dairy calves in relation to antimicrobial therapy and respiratory diagnostics. In addition, we studied the association of cured and uncured pneumonia with average daily gain (ADG) and cold carcass weight (CCW). The third objective was to determine the effects of arriving with lung consolidation on the probability of developing chronic unresponsive pneumonia and reduced performance. A total of 295 male dairy calves were intensively followed by qTUS and clinical scoring on 7 strategic occasions (wk 1, 2, 3, 4, 6, 8, and 12) during the production cycle. Of the calves, 17.6% (52/295) arrived with a lung consolidation ≥1 cm. At the first outbreak of respiratory disease (wk 1 after arrival), this incidence had risen to 30.8%. Initial therapy with tulathromycin and subsequently doxycycline appeared ineffective, resulting in a increase to 43.8% of calves having pneumonia in wk 4. At the start of the first outbreak (wk 1), the majority (86.8%) of the pneumonia cases were subclinical. At wk 4, the outbreak became more clinical, and treatment with amoxicillin resulted in a cure risk of 52.7%. Culture and nanopore sequencing diagnostics on nonendoscopic broncho-alveolar lavage (nBAL) samples identified bovine respiratory syncytial virus and Mycoplasma bovis as the dominant agents in the first outbreak. The isolated M. bovis strain showed mutations associated with macrolide resistance. The second outbreak was characterized by a Pasteurella multocida superinfection and isolation of multiple M. bovis strains from nBAL diagnostic testing. Evaluated over the complete observation period, 83.4% of the calves developed consolidations ≥1 cm on qTUS. Of these calves, 53.9% (135/246) were cured by antimicrobial therapy. Chronic pneumonia (≥30 subsequent days of pneumonia) was seen in 13.9% of the animals (n = 41). Calves with uncured or chronic pneumonia had a lower ADG (992 ± 174 g/d and 930 ± 146 g/d, respectively) compared with calves that never developed pneumonia (ADG = 1,103 ± 156 g/d). In contrast, calves that did fully cure trended toward a lower ADG than calves that never developed pneumonia, but differences were no longer significant. Also, the effect of uncured pneumonia was no longer significant for CCW. Calves with lung consolidation upon arrival had a lower ADG (981 ± 159 g/d vs. 1,045 ± 159 g/d) and were more likely to develop chronic pneumonia [odds ratio = 4.2; 95% confidence interval = 2.1-8.6] compared with calves without consolidation upon arrival. Animals with chronic pneumonia, in turn, had a lower CCW than animals without chronic pneumonia (10.3 ± 4.4 kg; 95% confidence interval: 1.6-19.1 kg). This study documents the consequences of subclinical pneumonia upon arrival and pneumonia developed later in the production cycle on production outcomes in a veal calf setting. Both qTUS and nBAL diagnostics provide important information, offering potential for better control and prevention of bovine respiratory disease in dairy calves." @default.
- W4308405425 created "2022-11-11" @default.
- W4308405425 creator A5001166892 @default.
- W4308405425 creator A5017648243 @default.
- W4308405425 creator A5031465782 @default.
- W4308405425 creator A5036608272 @default.
- W4308405425 creator A5063705619 @default.
- W4308405425 creator A5073263142 @default.
- W4308405425 creator A5074028748 @default.
- W4308405425 creator A5075830174 @default.
- W4308405425 creator A5084656029 @default.
- W4308405425 date "2023-01-01" @default.
- W4308405425 modified "2023-10-16" @default.
- W4308405425 title "Dynamics of subclinical pneumonia in male dairy calves in relation to antimicrobial therapy and production outcomes" @default.
- W4308405425 cites W1927348325 @default.
- W4308405425 cites W1965123449 @default.
- W4308405425 cites W1973834835 @default.
- W4308405425 cites W1987963802 @default.
- W4308405425 cites W1996061587 @default.
- W4308405425 cites W2024122964 @default.
- W4308405425 cites W2040380385 @default.
- W4308405425 cites W2048815790 @default.
- W4308405425 cites W2067482003 @default.
- W4308405425 cites W2080361131 @default.
- W4308405425 cites W2096784278 @default.
- W4308405425 cites W2105801299 @default.
- W4308405425 cites W2113811867 @default.
- W4308405425 cites W2119113479 @default.
- W4308405425 cites W2145424398 @default.
- W4308405425 cites W2160002645 @default.
- W4308405425 cites W2162023816 @default.
- W4308405425 cites W2284909719 @default.
- W4308405425 cites W2605487581 @default.
- W4308405425 cites W2738344444 @default.
- W4308405425 cites W2811255034 @default.
- W4308405425 cites W2888560867 @default.
- W4308405425 cites W2899358145 @default.
- W4308405425 cites W2942862620 @default.
- W4308405425 cites W2982946031 @default.
- W4308405425 cites W2999705563 @default.
- W4308405425 cites W3003805238 @default.
- W4308405425 cites W3004506836 @default.
- W4308405425 cites W3013030163 @default.
- W4308405425 cites W3015453652 @default.
- W4308405425 cites W3033610599 @default.
- W4308405425 cites W3035425171 @default.
- W4308405425 cites W3087818160 @default.
- W4308405425 cites W3094241128 @default.
- W4308405425 cites W3105535393 @default.
- W4308405425 cites W3110682212 @default.
- W4308405425 cites W3116240822 @default.
- W4308405425 cites W3134291399 @default.
- W4308405425 cites W3136726205 @default.
- W4308405425 cites W3154977719 @default.
- W4308405425 cites W3203636020 @default.
- W4308405425 cites W4200195632 @default.
- W4308405425 cites W4200306300 @default.
- W4308405425 cites W4205468114 @default.
- W4308405425 cites W4225989307 @default.
- W4308405425 cites W4229032099 @default.
- W4308405425 doi "https://doi.org/10.3168/jds.2022-22212" @default.
- W4308405425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36357203" @default.
- W4308405425 hasPublicationYear "2023" @default.
- W4308405425 type Work @default.
- W4308405425 citedByCount "3" @default.
- W4308405425 countsByYear W43084054252023 @default.
- W4308405425 crossrefType "journal-article" @default.
- W4308405425 hasAuthorship W4308405425A5001166892 @default.
- W4308405425 hasAuthorship W4308405425A5017648243 @default.
- W4308405425 hasAuthorship W4308405425A5031465782 @default.
- W4308405425 hasAuthorship W4308405425A5036608272 @default.
- W4308405425 hasAuthorship W4308405425A5063705619 @default.
- W4308405425 hasAuthorship W4308405425A5073263142 @default.
- W4308405425 hasAuthorship W4308405425A5074028748 @default.
- W4308405425 hasAuthorship W4308405425A5075830174 @default.
- W4308405425 hasAuthorship W4308405425A5084656029 @default.
- W4308405425 hasBestOaLocation W43084054251 @default.
- W4308405425 hasConcept C10389963 @default.
- W4308405425 hasConcept C113280763 @default.
- W4308405425 hasConcept C116675565 @default.
- W4308405425 hasConcept C126322002 @default.
- W4308405425 hasConcept C142724271 @default.
- W4308405425 hasConcept C203014093 @default.
- W4308405425 hasConcept C2776178081 @default.
- W4308405425 hasConcept C2777714996 @default.
- W4308405425 hasConcept C2777914695 @default.
- W4308405425 hasConcept C2779425085 @default.
- W4308405425 hasConcept C2780861368 @default.
- W4308405425 hasConcept C42972112 @default.
- W4308405425 hasConcept C71924100 @default.
- W4308405425 hasConceptScore W4308405425C10389963 @default.
- W4308405425 hasConceptScore W4308405425C113280763 @default.
- W4308405425 hasConceptScore W4308405425C116675565 @default.
- W4308405425 hasConceptScore W4308405425C126322002 @default.
- W4308405425 hasConceptScore W4308405425C142724271 @default.
- W4308405425 hasConceptScore W4308405425C203014093 @default.
- W4308405425 hasConceptScore W4308405425C2776178081 @default.
- W4308405425 hasConceptScore W4308405425C2777714996 @default.